Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SNAP29: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | SNAP29 |
| Full Name | Synaptosomal-Associated Protein 29 |
| Function | is a member of the SNAP25 family of SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) proteins[@snap2018][@snap2020]. |
| Subcellular Localization | </th><td>Cytoplasm, Plasma Membrane, Endosomes</td></tr> |
| Molecular Weight | 29 kDa |
| Pathways | NOTCH |
| GeneCards | SNAP29 |
| Human Protein Atlas | SNAP29 |
| Associated Diseases | Aging, Als, Ftd, Glioblastoma, Melanoma |
| Known Drugs/Compounds | rapamycin |
| Interactions | ACAT1, ACTB, AKT, ALZHEIMER, ALZHEIMER'S DISEASE, AMPK |
| KG Connections | 708 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
SNAP29["SNAP29"] -->|"Associated With"| Glioblastoma["Glioblastoma"]
SNAP29["SNAP29"] -->|"Associated With"| Tumor["Tumor"]
SNAP29["SNAP29"] -->|"Associated With"| Parkinson["Parkinson"]
SNAP29["SNAP29"] -->|"Associated With"| Ms["Ms"]
SNAP29["SNAP29"] -->|"Associated With"| Als["Als"]
SNAP29["SNAP29"] -->|"Therapeutic Target"| Neurodegeneration["Neurodegeneration"]
SNAP29["SNAP29"] -->|"Therapeutic Target"| Aging["Aging"]
SNAP29["SNAP29"] -->|"Activates"| Carcinoma["Carcinoma"]
VAMP8["VAMP8"] -->|"Associated With"| SNAP29["SNAP29"]
LAMP2["LAMP2"] -->|"Associated With"| SNAP29["SNAP29"]
GBM["GBM"] -->|"Associated With"| SNAP29["SNAP29"]
LC3["LC3"] -->|"Associated With"| SNAP29["SNAP29"]
EPG5["EPG5"] -->|"Associated With"| SNAP29["SNAP29"]
style SNAP29 fill:#8d4900,color:#e0e0e0
style Glioblastoma fill:#b71c1c,color:#e0e0e0
style Tumor fill:#b71c1c,color:#e0e0e0
style Parkinson fill:#b71c1c,color:#e0e0e0
style Ms fill:#b71c1c,color:#e0e0e0
style Als fill:#b71c1c,color:#e0e0e0
style Neurodegeneration fill:#b71c1c,color:#e0e0e0
style Aging fill:#b71c1c,color:#e0e0e0
style Carcinoma fill:#b71c1c,color:#e0e0e0
style VAMP8 fill:#8d4900,color:#e0e0e0
style LAMP2 fill:#8d4900,color:#e0e0e0
style GBM fill:#8d4900,color:#e0e0e0
style LC3 fill:#8d4900,color:#e0e0e0
style EPG5 fill:#8d4900,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Autophagosome-Lysosome Fusion | mediates | process | 0.95 |
| Autophagosome-Lysosome Fusion | involved_in | process | 0.90 |
| Autophagy | associated_with | process | 0.90 |
| autophagy pathway | participates_in | pathway | 0.90 |
| SNARE Complex Formation | inhibits | process | 0.88 |
| ubiquitin-proteasome | participates_in | pathway | 0.80 |
| Tumor | associated_with | disease | 0.75 |
| LYSOSOME | regulates | gene | 0.70 |
| Autophagy | activates | pathway | 0.70 |
| ULK1 | regulates | gene | 0.70 |
| STX17 | associated_with | gene | 0.70 |
| Schizophrenia | expressed_in | disease | 0.65 |
| Schizophrenia | associated_with | disease | 0.65 |
| Hepatitis | regulates | disease | 0.65 |
| Glioblastoma | associated_with | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Glioblastoma | therapeutic_target | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Autism | regulates | disease | 0.65 |
| Neuropathy | associated_with | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Schizophrenia | regulates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Als | encodes | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Ftd | associated_with | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Neurodegeneration | encodes | disease | 0.65 |
| Aging | encodes | disease | 0.65 |
| Melanoma | associated_with | disease | 0.65 |
| Infection | activates | disease | 0.65 |
| Bacterial Infection | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Neuroinflammation | regulates | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Infection | interacts_with | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SIDE | phosphorylates | protein | 0.85 |
| LC3 | associated_with | gene | 0.70 |
| SQSTM1 | associated_with | gene | 0.70 |
| VAMP8 | associated_with | gene | 0.70 |
| ULK1 | associated_with | gene | 0.70 |
| AUTOPHAGY | activates | gene | 0.70 |
| P62 | associated_with | gene | 0.70 |
| RB1CC1 | regulates | gene | 0.70 |
| MTOR | regulates | gene | 0.70 |
| RB1 | activates | gene | 0.70 |
| RB1 | regulates | gene | 0.70 |
| rapamycin | targets | drug | 0.70 |
| ATG | activates | gene | 0.70 |
| ATG | regulates | gene | 0.70 |
| RUBCNL | activates | gene | 0.70 |
| TFEB | associated_with | gene | 0.60 |
| EP300 | associated_with | gene | 0.60 |
| NDP52 | associated_with | gene | 0.60 |
| HDAC6 | associated_with | gene | 0.60 |
| RB1 | associated_with | gene | 0.60 |
| LAMP2A | associated_with | gene | 0.60 |
| MAP1LC3B | associated_with | gene | 0.60 |
| PRKN | associated_with | gene | 0.60 |
| PI3K | therapeutic_target | gene | 0.60 |
| BDNF | therapeutic_target | gene | 0.60 |
| AKT | associated_with | gene | 0.60 |
| BCL2 | associated_with | gene | 0.60 |
| FUNDC1 | associated_with | gene | 0.60 |
| PARKIN | associated_with | gene | 0.60 |
| UBIQUITIN | associated_with | gene | 0.60 |
| TNF | associated_with | gene | 0.60 |
| FIS1 | associated_with | gene | 0.60 |
| TGM2 | associated_with | gene | 0.60 |
| TP53 | associated_with | gene | 0.60 |
| VAMP7 | expressed_in | gene | 0.60 |
| NR4A1 | associated_with | gene | 0.60 |
| RIPK2 | associated_with | gene | 0.60 |
| MFF | associated_with | gene | 0.60 |
| TUFM | associated_with | gene | 0.60 |
| HAND | degrades | entity | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| IGF2BP1 | therapeutic_target | gene | 0.60 |
| TDP-43 | therapeutic_target | gene | 0.60 |
| FUS | transports | gene | 0.60 |
| STX17 | transports | gene | 0.60 |
| MAP1LC3 | associated_with | gene | 0.60 |
| AMPK | associated_with | gene | 0.60 |
| ACAT1 | associated_with | gene | 0.60 |
| ATG | associated_with | gene | 0.60 |
| METTL3 | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin- | 0.600 | neurodegeneration | What are the neuron-specific effects of |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning SNAP29 in their description or question text
No additional research found